Cefepim "MIP" 2 g pulver til injektions-/infusionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

cefepim "mip" 2 g pulver til injektions-/infusionsvæske, opløsning

mip pharma gmbh - cefepimdihydrochloridmonohydrat - pulver til injektions-/infusionsvæske, opløsning - 2 g

Physioneal 35 Glucose 1,36% w/v/13,6 mg/ml Clear-F peritonealdialysevæske Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

physioneal 35 glucose 1,36% w/v/13,6 mg/ml clear-f peritonealdialysevæske

baxter a/s - calciumchloriddihydrat, glucosemonohydrat, magnesiumchloridhexahydrat, natrium(s)-lactat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske - 13,6 mg/ml

Physioneal 35 Glucose 2,27% w/v/22,7 mg/ml Clear-F peritonealdialysevæske Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

physioneal 35 glucose 2,27% w/v/22,7 mg/ml clear-f peritonealdialysevæske

baxter a/s - calciumchloriddihydrat, glucosemonohydrat, magnesiumchloridhexahydrat, natrium(s)-lactat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske - 22,7 mg/ml

Physioneal 35 Glucose 3,86% w/v/38,6 mg/ml Clear-F peritonealdialysevæske Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

physioneal 35 glucose 3,86% w/v/38,6 mg/ml clear-f peritonealdialysevæske

baxter a/s - calciumchloriddihydrat, glucosemonohydrat, magnesiumchloridhexahydrat, natrium(s)-lactat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske - 38,6 mg/ml

Physioneal 40 Glucose 1,36% w/v/13,6 mg/ml Clear-F peritonealdialysevæske Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

physioneal 40 glucose 1,36% w/v/13,6 mg/ml clear-f peritonealdialysevæske

baxter a/s - calciumchloriddihydrat, glucosemonohydrat, magnesiumchloridhexahydrat, natrium(s)-lactat opløsning, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske - 13,6 mg/ml

Physioneal 40 Glucose 2,27% w/v/22,7 mg/ml Clear-F peritonealdialysevæske Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

physioneal 40 glucose 2,27% w/v/22,7 mg/ml clear-f peritonealdialysevæske

baxter a/s - calciumchloriddihydrat, glucosemonohydrat, magnesiumchloridhexahydrat, natrium(s)-lactat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske - 22,7 mg/ml

Physioneal 40 Glucose 3,86% w/v/38,6 mg/ml Clear-F peritonealdialysevæske Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

physioneal 40 glucose 3,86% w/v/38,6 mg/ml clear-f peritonealdialysevæske

baxter a/s - calciumchloriddihydrat, glucosemonohydrat, magnesiumchloridhexahydrat, natrium(s)-lactat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske - 38,6 mg/ml

Tygacil Europeiska unionen - danska - EMA (European Medicines Agency)

tygacil

pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibakterielle midler til systemisk brug, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler.. hensigtsmæssig brug af antibakterielle midler..

Zavicefta Europeiska unionen - danska - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler til systemisk brug, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

Ceftazidim "Fresenius Kabi" 2000 mg pulver til injektions-/infusionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

ceftazidim "fresenius kabi" 2000 mg pulver til injektions-/infusionsvæske, opløsning

fresenius kabi ab - ceftazidim - pulver til injektions-/infusionsvæske, opløsning - 2000 mg